These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 20142120)

  • 41. Early Detection of Cardiac Involvement in Systemic Sclerosis: The Added Value of Magnetic Resonance Imaging.
    Gargani L; Todiere G; Guiducci S; Bruni C; Pingitore A; De Marchi D; Bellando Randone S; Aquaro GD; Bazzichi L; Mosca M; Lombardi M; Pepe A; Matucci-Cerinic M; Picano E
    JACC Cardiovasc Imaging; 2019 May; 12(5):927-928. PubMed ID: 30553664
    [No Abstract]   [Full Text] [Related]  

  • 42. Cardiovascular magnetic resonance in systemic sclerosis: "Pearls and pitfalls".
    Mavrogeni SI; Schwitter J; Gargani L; Pepe A; Monti L; Allanore Y; Matucci-Cerinic M
    Semin Arthritis Rheum; 2017 Aug; 47(1):79-85. PubMed ID: 28522072
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ultrasonic videodensitometric analysis in scleroderma heart disease.
    Di Bello V; Ferri C; Giorgi D; Bianchi M; Bertini A; Martini A; Storino FA; Paterni M; Pasero G; Giusti C
    Coron Artery Dis; 1999; 10(2):103-10. PubMed ID: 10219516
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assessment of pericardial diseases and cardiac masses with cardiovascular magnetic resonance.
    Dawson D; Mohiaddin R
    Prog Cardiovasc Dis; 2011; 54(3):305-19. PubMed ID: 22014497
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cardiac Involvement in Systemic Sclerosis: Diagnostic Tools and Evaluation Methods.
    Smolenska Z; Barraclough R; Dorniak K; Szarmach A; Zdrojewski Z
    Cardiol Rev; 2019; 27(2):73-79. PubMed ID: 29994849
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Primary heart disease in systemic sclerosis (scleroderma): advances in clinical and pathologic features, pathogenesis, and new therapeutic approaches.
    Botstein GR; LeRoy EC
    Am Heart J; 1981 Nov; 102(5):913-9. PubMed ID: 7030042
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessment of heart involvement.
    Ferri C; Emdin M; Nielsen H; Bruhlmann P
    Clin Exp Rheumatol; 2003; 21(3 Suppl 29):S24-8. PubMed ID: 12889218
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cardiac involvement in scleroderma.
    Deswal A; Follansbee WP
    Rheum Dis Clin North Am; 1996 Nov; 22(4):841-60. PubMed ID: 8923599
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Myocardial perfusion-fibrosis pattern in systemic sclerosis assessed by cardiac magnetic resonance.
    Mavrogeni S; Bratis K; van Wijk K; Stavropoulos E; Hautemann D; Reiber JH; Kolovou G
    Int J Cardiol; 2012 Sep; 159(3):e56-8. PubMed ID: 22227256
    [No Abstract]   [Full Text] [Related]  

  • 50. Advanced cardiovascular magnetic resonance myocardial perfusion imaging: high-spatial resolution versus 3-dimensional whole-heart coverage.
    Motwani M; Jogiya R; Kozerke S; Greenwood JP; Plein S
    Circ Cardiovasc Imaging; 2013 Mar; 6(2):339-48. PubMed ID: 23512780
    [No Abstract]   [Full Text] [Related]  

  • 51. Systemic sclerosis and the heart.
    Parks JL; Taylor MH; Parks LP; Silver RM
    Rheum Dis Clin North Am; 2014 Feb; 40(1):87-102. PubMed ID: 24268011
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Progress in Understanding, Diagnosing, and Managing Cardiac Complications of Systemic Sclerosis.
    Hung G; Mercurio V; Hsu S; Mathai SC; Shah AA; Mukherjee M
    Curr Rheumatol Rep; 2019 Dec; 21(12):68. PubMed ID: 31813082
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical utility of echocardiography and magnetic resonance imaging for detecting cardiac complications in systemic sclerosis. A case report.
    Cojan Minzat BO; Cioanca C; Mihalcea I; Lupu S; Agoston-Coldea L
    Med Ultrason; 2015 Jun; 17(2):262-5. PubMed ID: 26052582
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High Field Cardiac Magnetic Resonance Imaging: A Case for Ultrahigh Field Cardiac Magnetic Resonance.
    Niendorf T; Schulz-Menger J; Paul K; Huelnhagen T; Ferrari VA; Hodge R
    Circ Cardiovasc Imaging; 2017 Jun; 10(6):. PubMed ID: 28611118
    [No Abstract]   [Full Text] [Related]  

  • 55. [Heart involvement in systemic sclerosis].
    Kruszec A; Kotyla P
    Pol Merkur Lekarski; 2016 Sep; 41(243):156-159. PubMed ID: 27755519
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Understanding and managing cardiac involvement in systemic sclerosis.
    Moysidou GS; Dara A; Arvanitaki A; Skalkou A; Pagkopoulou E; Daoussis D; Kitas GD; Dimitroulas T
    Expert Rev Clin Immunol; 2023 Mar; 19(3):293-304. PubMed ID: 36690592
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Magnetic resonance imaging in cardiac amyloidosis.
    Pennell DJ; Maceira AM
    JACC Cardiovasc Imaging; 2009 Dec; 2(12):1378-80. PubMed ID: 20083071
    [No Abstract]   [Full Text] [Related]  

  • 58. Myocardial Perfusion, Fibrosis, and Contractility in Children With Kawasaki Disease.
    Muthusami P; Luining W; McCrindle B; van der Geest R; Riesenkampff E; Yoo SJ; Seed M; Manlhiot C; Grosse-Wortmann L
    JACC Cardiovasc Imaging; 2018 Dec; 11(12):1922-1924. PubMed ID: 30121268
    [No Abstract]   [Full Text] [Related]  

  • 59. Low-Field Cardiac Magnetic Resonance Imaging: A Compelling Case for Cardiac Magnetic Resonance's Future.
    Simonetti OP; Ahmad R
    Circ Cardiovasc Imaging; 2017 Jun; 10(6):. PubMed ID: 28611117
    [No Abstract]   [Full Text] [Related]  

  • 60. Stress perfusion-fibrosis cardiac magnetic resonance detects early heart involvement in young asymptomatic, homozygous familial hyperlipidemia with normal routine non-invasive evaluation.
    Mavrogeni S; Bratis K; Papachristou P; Giannakopoulou E; Karanasios E; Kolovou G; van Wijk K; Hautemann D; Reiber JH; Papadopoulos G
    Int J Cardiol; 2013 Oct; 168(4):4570-2. PubMed ID: 23896536
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.